Targeting Engineered Nanoparticles for Breast Cancer Therapy

Breast cancer (BC) is the second most common cancer in women globally after lung cancer. Presently, the most important approach for BC treatment consists of surgery, followed by radiotherapy and chemotherapy. The latter therapeutic methods are often unsuccessful in the treatment of BC because of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesan, Kumar, Wang, Yan, Gao, Fei, Liu, Qingqing, Zhang, Chen, Li, Peng, Zhang, Jinming, Chen, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623926/
https://www.ncbi.nlm.nih.gov/pubmed/34834243
http://dx.doi.org/10.3390/pharmaceutics13111829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623926/
https://www.ncbi.nlm.nih.gov/pubmed/34834243
http://dx.doi.org/10.3390/pharmaceutics13111829

Ejemplares similares